|Delivery||Report Code||Available Format|
|24-72 Working Hours||LS11114|
Infection Surveillance Solutions Market Overview
The global infection surveillance solutions market size is expected to register a considerable growth in the near future. The market is growing due to the rising prevalence of life-threatening infections, such as influenza, typhoid, sepsis, severe acute respiratory syndrome, and tuberculosis, around the world, which has led to an increased requirement for effective infection control procedures in healthcare facilities. Apart from this, governments are also focusing on spreading information regarding infectious diseases and is circulating infection control and surveillance guidelines around different healthcare settings.
The solutions provided by infection surveillance technology are services and software. The software category is predicted to hold a significant infection surveillance solutions market share in the coming years. Several vendors are providing flexible and comprehensive infection surveillance software. Furthermore, healthcare facilities are increasingly adopting software, as the software can be customized for real-time and instant contact tracking tasks and efficient organization surveillance. The software category is further divided into web-based and on-premises. The faster growth is projected to registered by the services category in the near future. The category is further divided into implementation, product support & maintenance, and training & consulting.
The major end users of infection surveillance solutions market offerings are long-term care facilities, hospitals, and others (which include academic institutes and ambulatory care centers). The hospitals category is further divided into small hospitals, medium-sized hospitals, and large hospitals. The long-term care facilities are divided include assisted living facilities, skilled nursing facilities, and nursing homes. In these healthcare settings, different infection surveillance solutions are utilized to record exact information of patient and employee health, medical records in real-time monitoring, and surgical databases.
Geographically, North America held the largest infection surveillance solutions market share in the past. The reasons for this were the rising requirement for decreasing hospital-acquired infections (HAI) and the increase in number of healthcare facilities in the region. In addition to this, the presence of key players, which offer advanced in-premise and web-based software, is driving the growth of the regional market. Attributed to these factors, the region is further predicted to contribute the largest revenue share to the market in the near future.
The Asia-Pacific region is expected to witness the fastest growth in the coming years due to the rising awareness and accessibility to innovative healthcare facilities, rapidly improving health insurance sector, increasing healthcare expenditure, and surging incidence of HAIs.
Infection Surveillance Solutions Market Dynamics
One of the primary driving factors of the infection surveillance solutions market growth is the rising prevalence of HAIs across the world. HAIs occur due to reduced immunity of patients, practices that decrease the effects of ongoing medications, increased healthcare expenditures, negligence, and poor hygiene. In healthcare settings, HAIs have been identified as one of the major causes of mortality, which is why several healthcare facilities are adopting technologies such as infection surveillance solutions for improving infection control processes and strategies. Infection surveillance allows continuous management and monitoring of data of HAIs for early detection of disease, public health assessment, and for ensuring appropriate execution of preventive measures.
Opportunities and Trends
The key trends being observed in the infection surveillance solutions market are the shifting preference of healthcare providers towards automation in healthcare facilities and the rising requirement for web-based solutions and mobile platforms. In addition to this, the introduction of cloud-based software in the domain and rising adoption of infection surveillance in emerging economies across Latin America and Asia-Pacific regions are projected to open up wide opportunities for players operating in the market.
Infection Surveillance Solutions Market Competitive Landscape
The players in the global infection surveillance solutions market are engaging in collaborations for expanding their service and product offerings and are also introducing new treatment methods in the industry. For instance, in June 2017, a molecular test developed by Becton, Dickinson and Company, BD MAX, was approved by the United States Food and Drug Administration for detecting intestinal bacteria which causes infectious diarrhea. Apart from this, the test aimed to detect majority of pathogens that cause gastroenteritis, which eventually leads to hospitalization.
Some other key players in the infection surveillance solutions market include Baxter International Inc., Premier Inc., Gojo Industries Inc., Deb Group Ltd., Truven Health Analytics (An IBM Company), HyGreen Inc., RL Solutions, and Atlas Medical Software.